APA (7th ed.) Citation

A, B., S, E., S, H., I, R., M, R., D, R., . . . E, W. (2021). Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer. Oral oncology, 121, 105477. https://doi.org/10.1016/j.oraloncology.2021.105477

Chicago Style (17th ed.) Citation

A, Boucher, et al. "Canadian Consensus Statement on the Management of Radioactive Iodine-resistant Differentiated Thyroid Cancer." Oral Oncology 121 (2021): 105477. https://doi.org/10.1016/j.oraloncology.2021.105477.

MLA (9th ed.) Citation

A, Boucher, et al. "Canadian Consensus Statement on the Management of Radioactive Iodine-resistant Differentiated Thyroid Cancer." Oral Oncology, vol. 121, 2021, p. 105477, https://doi.org/10.1016/j.oraloncology.2021.105477.